Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects

NCT02201368 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped IMP management difficulties

Conditions

Long-chain Fatty Acid Transport Deficiency

Interventions

DRUG: Triheptanoin (SpezialölÒ 107®)
DIETARY_SUPPLEMENT: MCT (Medium-Chain Triglycerides)

Sponsor

Maria Luz Couce Pico

Collaborators

[object Object]